Fundraising Fox

Alucent Medical

Sioux Falls, US · Founded 2014 · Delaware corporation

Biotech

Founders & leadership

RH
Ryan HansenExecutive

Board

DK
David KapaskaBoard director
FS
Fred SluneckaBoard director
JN
Julie NortonBoard director
ME
Michael ElliotBoard director
JC
James CorbettBoard director

Reported raises · per SEC filings

Form D private placements

$46.6M disclosed across 3 rounds · 2015–2023

▶$11.2MraisedApr 2023 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Julie LauttDirector
  • James CorbettDirector
  • Bruce KrattenmakerExecutive Officer
  • Kevin WarnerExecutive Officer
  • Colin JacksonExecutive Officer
  • Myles GreenbergExecutive Officer, Director
  • David FlicekDirector
  • Katalin KauserExecutive Officer
  • Daniel PelakDirector
  • Nick PappasDirector
  • James IsaacsonExecutive Officer
  • Henry HauserExecutive Officer
Offering amount
$11.2M
Amount sold
$11.2M
First sale
Apr 2023
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$35MraisedOct 2020 · 3 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Dan PelakDirector
  • David FlicekDirector
  • Myles D. GreenbergExecutive Officer, Director
  • James CorbettDirector
  • Scott MayfieldExecutive Officer
  • Ryan HansenDirector
  • Pat CostelloDirector
  • Julie N. LauttDirector
Offering amount
$35M
Amount sold
$35M
First sale
Sep 2020
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$400KraisedJan 2015 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Julie NortonDirector
  • David KapaskaDirector
  • Michael ElliotDirector
  • Ryan HansenExecutive Officer, Director
  • James CorbettDirector
  • Fred SluneckaDirector
Offering amount
$400K
Amount sold
$400K
First sale
Jan 2015
Incorporated
Corporation, Delaware, 2014
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

Salt Lake City Utah based Alucent Biomedical is raising $34,999,999.00 in New Equity Investment. - intelligence360intelligence360.news · Nov 2020Alucent wins FDA nod for trial of novel drug-device PVD treatment - Drug Delivery Businessdrugdeliverybusiness.com · May 2017

Frequently asked questions

How much funding has Alucent Medical raised?
Alucent Medical has disclosed $46.6M raised across 3 rounds.
Where is Alucent Medical headquartered?
Alucent Medical is headquartered in Sioux Falls, US.